Menu
Menu
Randomized, controlled PMCF study regarding the efficacy of the application of MBST magnetic resonance therapy in postsurgical setting after TEP implantation
Clinical lead: Dr. med. Lars Stephan
Test centre: Sportorthopädie Dresden, 01099 Dresden, Germany; Städtisches Klinikum Dresden
Design: 114 patients (57 per treatment arm); patients in the active treatment arm receive 10 MBST treatment sessions in addition to the standard therapy after TEP implantation due to gonarthrosis
Endpoints: Primary: Range of Motion; Secondary: Oxford Knee Score, Knee Injury Osteoarthritis Outcome Score, Knee Society Score, EQ-5D, NRS pain scale, Safety: incidents, side effects, complications
Time frame: expected for completion at the end of 2025
Radiological And Self-Reported Outcomes of MBST® in Patients with Osteoporosis: A Retrospective Study in Qatar
Clinical lead: Dr. Emmanuel Tolessa
Test centre: DOC Medical Center, Doha, Qatar
Time frame: end of 2025
Continuous basic research of the active principle, signalling pathways, physiological processes
Head of research: PD Dr. Margit Christine Egg; Assistance: Dr. Viktoria Thöni
Test centre: Institute of Zoology, University of Innsbruck, Austria
Last publication: V. Thöni, A. Buchter, A. Flarer, J. Lampe, C. Schlegel & M. Egg., 2025: Understanding therapeutic nuclear magnetic resonance (tNMR): splitting of components indicates its unique efficacy, Poster presentation, BiOS, 2025, San Francisco, California, USA, in Proceedings Volume 13340, Quantum Effects and Measurement Techniques in Biology and Biophotonics II; 133400E (2025)
This popup shows the full story from each testimonial when “Story lesen” is clicked. You don’t need to edit this text — it will be replaced automatically.
